Therefore, FN1 may mediate immunosuppression through two mechanisms: (1) as an ECM scaffold, its rigid structure provides physical residence sites for immunosuppressive cells; (2) by upregulating PD-L1 expression in tumor cells through integrin signaling, indirectly inhibiting T-cell activity (21). The gene discussed is FN1; the disease is neoplasm.